88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

CARsgen Submitted Responses to FDA Observations SHANGHAI , April 29, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Laekna Releases 2023 ESG Report SHANGHAI and WARREN, N.J. , April 29, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, released its 2023 Environmental, Social and Governance ... 2024-04-29T Health Care/Hospital Medical/Pharmaceuticals
Henlius Trastuzumab Receives FDA Approval in the United States SHANGHAI , April 29, 2024 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's business partner, Accord BioPharma Inc. (the U.S. specialty division of Intas Pharmaceuticals, ... 2024-04-29T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule GAITHERSBURG, Md. , April 29, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Technoderma Medicines Advances TDM-180935 Atopic Dermatitis Clinical Program with Phase 2 Trial CHENGDU, China , April 29, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule GAITHERSBURG, Md. , April 29, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Prota Therapeutics' CEO Mimi Tang honoured at BioMelbourne Network's Women in Leadership Awards 2024 MELBOURNE, Australia , April 29, 2024 /PRNewswire/ -- Prota Therapeutics ' CEO Professor Mimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards. Professor ... 2024-04-29T Health Care/Hospital Medical/Pharmaceuticals
WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations Revenue Reached RMB7,982 Million ; Excluding COVID-19 Commercial Projects, Down 1.8% Net Profit Attributable to the Owners of the Company Reached RMB1,942 Million ; Diluted Earnings per Share (EPS) ... 2024-04-29T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative BEIJING , April 29, 2024 /PRNewswire/ -- In recent years, the rapid development of artificial intellig ence has introduced new possibilities across numerous scientific disciplines. As an AI for Science ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
INTREPID Alliance Landscape of Promising Antivirals in Clinical Development Reveals Gaps in Global Defense Against Potential Future Pandemics Detailed scientific analysis of antiviral pipeline identifies most promising clinical compounds aligned with 100 Days Mission global preparedness recommendations ... 2024-04-29T Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2024

Suntek Computer Systems Limited.

All rights reserved